Site Index

Journal Options

2008: July | April | January

2007: October

2007: March

2007: February

2007: January

2006: December

2006: November

2006: October

2006: July

2006: June

2006: April

2006: March

2006: January

2005: December

2005: November

2005: October

2005: August

2005: July

2005: June

2005: May

2005: April

2005: March

2005: February

2005: January

2004: December

2004: November

Conference Coverage

2004 International AIDS Conference

2006 Annual Meeting of the Infectious Disease Society of America

2003 Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting

2007 Interscience Conference on Antimicrobial Agents and Chemotherapy

2005 European AIDS Conference

2005 International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV and the 2005 European AIDS Clinical Society Conference

2003 European AIDS Conference

2006 European HIV Drug Resistance Workshop

2004 International Congress on Drug Therapy in HIV Infection

2006 International Congress on Drug Therapy in HIV Infection

2005 International Workshop on Targeting HIV Entry

2004 International Workshop on Adverse Drug Reactions And Lipodystrophy in HIV

2005 International Workshop on Adverse Drug Reactions And Lipodystrophy in HIV

2007 European AIDS Conference

2003 International Conference on Malignancies in AIDS and Other Immunodeficiencies

2008 International AIDS Conference

2004 International Workshop on HIV and Hepatitis Coinfection

2003 International AIDS Society Conference on HIV Pathogenesis and Treatment

2005 International Workshop on Clinical Pharmacology of HIV Therapy

Coverage of the 2006 International Workshop on Clinical Pharmacology of HIV Therapy

2007 International Workshop on Clinical Pharmacology of HIV Therapy

2004 International HIV Drug Resistance Workshop

2005 International HIV Drug Resistance Workshop

2006 International HIV Drug Resistance Workshop

2007 International HIV Drug Resistance Workshop

2003 Conference on Retroviruses and Opportunistic Infections

2004 Conference on Retroviruses and Opportunistic Infections

2005 Conference on Retroviruses and Opportunistic Infections

2006 Conference on Retroviruses and Opportunistic Infections

2007 Conference on Retroviruses and Opportunistic Infections

2008 Conference on Retroviruses and Opportunistic Infections

2005 International AIDS Society Conference on HIV Pathogenesis and Treatment

2004 International Workshop on Clinical Pharmacology of HIV Therapy

2006 Interscience Conference on Antimicrobial Agents and Chemotherapy

4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention

2006 International AIDS Conference

2005 Interscience Conference on Antimicrobial Agents and Chemotherapy

2004 Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

Conference Calendar

Management Series

Cardiovascular Risk Factors and Metabolic Complications in Patients Receiving HAART

Dyslipidemia and Other Cardiovascular Risk Factors in HIV: Causes, Clinical Significance, and Management Strategies

Double-Boosted Protease Inhibitors

Fine-Tuning Antiretroviral Therapy in HIV-Infected Patients With Virologic Suppression: Strategies to Address Toxicity, Convenience, and Quality of Life

Fixed-Dose Combination NRTIs in the Treatment of HIV Infection

Choosing an Initial Protease Inhibitor for PI-Naive Patients

Insulin Resistance and Body Shape Changes in HIV-Infected Patients

The Role of Integrase Inhibitors in HIV Management

Strategies for the Management of Multiclass-Resistant Patients

Neurologic Aspects of HIV/AIDS: New Insights and Management Advances

Treatment Strategies With NNRTIs: Use in First-Line vs Later Regimens

NNRTIs in Clinical Practice: An Update

Optimizing the NRTI Backbone in HIV-Infected Patients Receiving Antiretroviral Therapy

The Importance of Pharmacokinetic Factors in Successful Antiretroviral Therapy

Psychiatric Disorders in HIV-Infected Patients

Antiretroviral Resistance and Options for Sequencing

When to Start, What to Use: A Master Class in the Use of First-Line Antiretroviral Therapy

Treatment Updates

Managing Insulin Resistance in HIV-Infected Patients

Managing Dyslipidemia in HIV-Infected Patients on Therapy: Switch Antiretrovirals or Add Lipid-Lowering Agents?

New Insights Into the Use of PIs Across the Treatment Spectrum

Evolving Concepts in Antiretroviral Therapy

Novel Agents for Treatment-Experienced Patients: Faculty Mentoring for Managing Challenging Cases

Integrating New Antiretroviral Agents Into Therapeutic Strategies for Treatment-Experienced Patients

Answering the Questions: Practical Management Strategies to Address Cardiovascular Risk in HIV

New Classes of Antiretrovirals: The Potential Clinical Role of Integrase Inhibitors and Entry Inhibitors

Managing Cardiovascular Risk in HIV-Infected Patients: The Role of Antiretroviral Selection

New Classes of Antiretrovirals: The Clinical Role of Integrase Inhibitors and Entry Inhibitors

The Clinical Impact of Next-Generation NNRTIs: Recent Research and Practical Treatment Strategies

Evolving Insights Into the Optimal Timing of Antiretroviral Therapy

Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents

Right From the Start: Optimizing First-Line Antiretroviral Therapy

Simple From the Start: The Importance of Treatment Convenience in Antiretroviral Therapy

HIV Entry and Tropism: New Strategies for Effective Antiretroviral Therapy

The New Anatomy of Effective Antiretroviral Therapy

Use of Boosted Protease Inhibitor-Based Regimens in Treatment-Experienced Patients

Managing Metabolic Issues and Cardiovascular Risk in HIV-Infected Patients

Choosing and Using New Antiretrovirals for Multiclass-Experienced HIV-Infected Patients

New Strategies for Regaining Control of HIV Replication in Treatment-Experienced Patients

Understanding HIV Drug Resistance Testing: When to Test, How to Interpret

Managing Drug-Drug Interactions in the Changing Landscape of HIV

Redefining the Frontiers of First-Line Antiretroviral Therapy: A Decade of Progress in Effective HAART

HIV Lessons Learned

Preventing and Managing Antiretroviral Side Effects

Antiretroviral Strategies for the Management of HIV Infection

Metabolic Complications in HIV-Infected Patients

Recent Advances in Managing Neurologic Adverse Effects of Antiretroviral Therapy

New Agents and Treatment Strategies for Treatment-Experienced HIV Patients

New Protease Inhibitors, New Treatment Goals: Attaining Undetectable Viral Load in Antiretroviral-Experienced Patients

New Standards and Strategies in Antiretroviral Therapy

Novel Classes of Antiretrovirals: Update on CCR5 Antagonists and Integrase Inhibitors

The Economics of HIV in the HAART Era

Primary Care and Prevention

Refining Antiretroviral Regimens: Improving Tolerability and Convenience for Virologically Suppressed HIV-Infected Patients

Resistance Testing in HIV

A Decade of HAART: Past, Present, and Future Role of Protease Inhibitors

New and Investigational Anti-HIV Agents: Switching Strategies and Durability

Annual Updates

HIV/AIDS Annual Update 2002

HIV/AIDS Annual Update 2003

HIV/AIDS Annual Update 2004

HIV/AIDS Annual Update 2005

HIV/AIDS Annual Update 2006

HIV/AIDS Annual Update 2007

HIV/AIDS Annual Update 2008

Case Challenges

From Theory to Practice: Strategies for the Successful Management of Treatment-Experienced Patients

Use of Resistance Testing to Guide Therapy in HIV-Infected Patients with Multiple Regimen Failure

News & Comments

2006: May | April | March | February | January

2005: December

2005: November

2005: October

2005: September

2005: August

2005: July

2005: June

2005: May

2005: April

2005: March

2005: February

2005: January

2004: December

2004: November

2004: October

2004: September

2004: August

2004: July

2004: June

2004: May

2004: April

2004: March

2004: February

2004: January

2003: December

2003: November

2003: October

2003: September

2003: August

2003: July

2003: June

2003: May

2003: April

2003: March

2003: February

Expert Viewpoints

Resources

Animation Downloads

Slideset Downloads

Drugs

Guidelines

Featured Content

Integrating New ARV Agents Into Therapeutic Strategies

Interact with Eric S. Daar, MD, in a new Virtual Presentation of clinical case scenarios.

IAC 2008 Conference Coverage From Mexico City

Official Conference Coverage of the latest data from the meeting in Mexico City.

Stay Tuned: Evolving Concepts in ARV Therapy

Join Program Chair Andrew R. Zolopa, MD, for the latest edition of this podcast newsmagazine.